299 related articles for article (PubMed ID: 32341066)
1. Innate Immunity in Hepatitis C Virus Infection.
Schwerk J; Negash A; Savan R; Gale M
Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 32341066
[TBL] [Abstract][Full Text] [Related]
2. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E; Gonzalez VD; Li Q; Modi AA; Chen W; Noureddin M; Rotman Y; Liang TJ
Gastroenterology; 2012 Apr; 142(4):978-88. PubMed ID: 22248663
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Wong MT; Chen SS
Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity and HCV.
Heim MH
J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Yang DR; Zhu HZ
World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
[TBL] [Abstract][Full Text] [Related]
6. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
7. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
Bruening J; Weigel B; Gerold G
J Immunol Res; 2017; 2017():7232361. PubMed ID: 28255563
[TBL] [Abstract][Full Text] [Related]
8. Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review.
Shaheen M; Afzal S; Khubaib B; Amin I; Shahid M; Idrees M
Crit Rev Eukaryot Gene Expr; 2020; 30(3):223-229. PubMed ID: 32749108
[TBL] [Abstract][Full Text] [Related]
9. Insights into antiviral innate immunity revealed by studying hepatitis C virus.
Horner SM
Cytokine; 2015 Aug; 74(2):190-7. PubMed ID: 25819428
[TBL] [Abstract][Full Text] [Related]
10. Interferons and hepatitis C virus.
Heim MH
Swiss Med Wkly; 2012; 142():w13586. PubMed ID: 22573217
[TBL] [Abstract][Full Text] [Related]
11. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
[TBL] [Abstract][Full Text] [Related]
12. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
13. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
Grzegorzewska AE
Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
[TBL] [Abstract][Full Text] [Related]
15. Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.
Pagliaccetti NE; Robek MD
J Interferon Cytokine Res; 2010 Aug; 30(8):585-90. PubMed ID: 20645875
[TBL] [Abstract][Full Text] [Related]
16. Role of Interferons in Chronic Hepatitis C Infection.
Scagnolari C; Monteleone K; Cacciotti G; Antonelli G
Curr Drug Targets; 2017; 18(7):844-850. PubMed ID: 26844564
[TBL] [Abstract][Full Text] [Related]
17. Organ system view of the hepatic innate immunity in HCV infection.
Bang BR; Elmasry S; Saito T
J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
[TBL] [Abstract][Full Text] [Related]
19. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection.
Holmes JA; Carlton-Smith C; Kim AY; Dumas EO; Brown J; Gustafson JL; Lauer GM; Silva ST; Robidoux M; Kvistad D; Alatrakchi N; Tonnerre P; Cohen DE; Zhang H; Shulman NS; Chung RT
J Viral Hepat; 2019 Mar; 26(3):362-372. PubMed ID: 30450781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]